Streetbeat News

Stock Prices

GILT

Needham analyst Ryan Koontz initiates coverage on Gilat Satellite Networks Ltd (NASDAQ:GILT) with a Buy rating and a price target of $7. He anticipates rising profitability and FCF in the company's Peru business and believes GILT can take advantage of rapidly expanding opportunities in the multi-orbit satellite sector. The company's Peru terrestrial network is nearing completion, and he expects a near-term upturn in its profits and FCF. GILT shares traded higher by 6.27% at $6.10 on the last check Tuesday.

Portfolio Pulse from Anusuya Lahiri

June 27, 2023 | 8:00 pm

MU

Raymond James analyst Srini Pajjuri maintains an Outperform rating on Micron Technology, Inc (NASDAQ:MU), despite expecting a potential revenue decline due to China's CAC decision. However, he believes the impact will be short-lived and anticipates a cyclical recovery starting in the second half of FY23. He also expects customer inventories to normalize by the calendar 4Q and predicts better supply discipline in the industry due to the current downturn.

Portfolio Pulse from Anusuya Lahiri

June 27, 2023 | 7:54 pm

AUR

Shares of Aurora Innovation are trading higher, likely due to overall market strength.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 7:54 pm

REGN

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares fell after the FDA issued a Complete Response Letter (CRL) for aflibercept 8 mg Biologics License application due to an ongoing review of inspection findings at a third-party filler. No issues were identified with the drug's clinical efficacy or safety, and no additional clinical data or trials have been requested. The company is committed to working with the FDA and the third-party filler to bring the drug to patients as quickly as possible.

Portfolio Pulse from Ryan Gustafson

June 27, 2023 | 7:53 pm

COIN

Coinbase Global shares are trading higher, possibly due to a recent rise in Bitcoin and positive comments from Baupost Group CEO Seth Klarman.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 7:48 pm

BAM

Brookfield Asset Management's shares are trading higher following a proposal by Brookfield Reinsurance to acquire AEL.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 7:43 pm

MNMD

MindMed (NASDAQ:MNMD) announced that shareholders elected all six of its nominees at the annual meeting, indicating support for the company's current R&D strategy. The new board of directors includes CEO Robert Barrow, Dr. Suzanne Bruhn, Dr. Roger Crystal, David Gryska, Andreas Krebs, and Carol A. Vallone. The company is looking forward to two key clinical readouts expected later this year.

Portfolio Pulse from Lara Goldstein

June 27, 2023 | 7:36 pm

REGN

Regeneron Pharmaceuticals' shares are trading lower after the FDA declined to approve a higher-dose version of EYLEA.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 7:34 pm

LMT

Over the past 20 years, Lockheed Martin (NYSE:LMT) has outperformed the market by 4.26% on an annualized basis, producing an average annual return of 11.86%. If an investor had bought $100 of LMT stock 20 years ago, it would be worth $935.09 today.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 7:30 pm

LLY

Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 30.13% on an annualized basis, producing an average annual return of 40.06%. If an investor had bought $100 of LLY stock 5 years ago, it would be worth $542.20 today. Eli Lilly currently has a market capitalization of $439.19 billion.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 7:30 pm